Pseudo-differentiation syndrome
<p class="MsoNormal" style="text-align: justify; line-height: 200%; text-indent: 0.5in; margin: 12pt 0in 10pt;"><span style="line-height: 200%;">A patient with relapsed acute myeloid leukemia (<strong><span style="ba...
Saved in:
| Main Authors: | Fathi Jehani, Dina Khalaf |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2011-01-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | http://www.mjhid.org/article/view/8551 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Selinexor in combination with venetoclax and decitabine in patients with refractory myelodysplastic syndrome previously exposed to hypomethylating agents: three case reports
by: Yunshuo Xiao, et al.
Published: (2024-12-01) -
Better Response and Prognosis of Venetoclax Plus Hypomethylating Agents Over Intensive Chemotherapy in Young Adults With Newly Diagnosed ASXL1‐Mutated Acute Myeloid Leukemia
by: Yiming Cai, et al.
Published: (2025-07-01) -
Efficacy and safety of venetoclax and azacitidine for acute myeloid leukemia in China: a real-world single-center study
by: Jie-Fei Bai, et al.
Published: (2025-06-01) -
Combination of hypomethylating agents and inhibitor of BCL-2 in treatment of patients with relapsed acute myeloid leukemia: S.P. Botkin hospital experience
by: M. A. Granatkin, et al.
Published: (2023-03-01) -
Challenging management of severe differentiation syndrome in pediatric acute promyelocytic leukemia treated with ATRA/ATO
by: Alessandro Molinaro, et al.
Published: (2022-02-01)